Sterling Investment Advisors (Pennsylvania)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-376
Closed -$29K 178
2022
Q2
$29K Buy
376
+3
+0.8% +$228 0.01% 286
2022
Q1
$27K Buy
373
+42
+13% +$2.82K 0.01% 328
2021
Q4
$21K Sell
331
-3,063
-90% -$180K 0.01% 358
2021
Q3
$201K Buy
3,394
+18
+0.5% +$1.19K 0.06% 146
2021
Q2
$226K Buy
3,376
+19
+0.6% +$1.24K 0.07% 143
2021
Q1
$212K Buy
3,357
+19
+0.6% +$1.18K 0.07% 137
2020
Q4
$207K Buy
3,338
+18
+0.5% +$1.11K 0.07% 130
2020
Q3
$200K Buy
3,320
+19
+0.6% +$1.14K 0.08% 125
2020
Q2
$194K Buy
3,301
+876
+36% +$52.4K 0.08% 127
2020
Q1
$135K Buy
2,425
+17
+0.7% +$1.04K 0.07% 128
2019
Q4
$154K Buy
2,408
+17
+0.7% +$974 0.07% 126
2019
Q3
$121K Buy
2,391
+21
+0.9% +$987 0.06% 142
2019
Q2
$107K Sell
2,370
-329
-12% -$15.3K 0.05% 147
2019
Q1
$129K Buy
2,699
+19
+0.7% +$946 0.07% 134
2018
Q4
$139K Buy
2,680
+17
+0.6% +$913 0.08% 126
2018
Q3
$165K Buy
2,663
+663
+33% +$39.3K 0.09% 122
2018
Q2
$110K Sell
2,000
-27,150
-93% -$1.47M 0.07% 136
2018
Q1
$1.84M Sell
29,150
-980
-3% -$63K 1.13% 23
2017
Q4
$1.85M Buy
30,130
+65
+0.2% +$4.07K 1.14% 25
2017
Q3
$1.92M Sell
30,065
-822
-3% -$48K 1.27% 22
2017
Q2
$1.72M Buy
30,887
+2
+0% +$109 1.15% 26
2017
Q1
$1.68M Buy
30,885
+1,251
+4% +$68.6K 1.21% 25
2016
Q4
$1.73M Buy
+29,634
New +$1.62M 1.39% 22

Other funds holding BMY

Sterling Investment Advisors (Pennsylvania)'s BMY Position: Q3 2022 in Review

Sterling Investment Advisors (Pennsylvania) sold out of Bristol-Myers Squibb (BMY) in Q3 2022, closing a stake of 376 shares — an estimated $29K sold.

Sterling Investment Advisors (Pennsylvania) first reported a position in BMY in Q4 2016 and held it in 23 quarters. The position peaked at $1.92M in Q3 2017. 2,470 funds tracked by Wall St. Rank hold BMY as of Q3 2022.

  • Sterling Investment Advisors (Pennsylvania) reported no remaining Bristol-Myers Squibb position as of Q3 2022 after selling out during the quarter.
  • Sterling Investment Advisors (Pennsylvania) sold 376 Bristol-Myers Squibb shares in Q3 2022, an estimated $29K.
  • Sterling Investment Advisors (Pennsylvania) first reported a position in Bristol-Myers Squibb in Q4 2016 and held it in 23 quarters.
  • Sterling Investment Advisors (Pennsylvania)'s Bristol-Myers Squibb position peaked at $1.92M in Q3 2017.
  • 2,470 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.

Based on Sterling Investment Advisors (Pennsylvania)'s 13F filing for Q3 2022, filed 3 Nov 2022.